Bioorthogonally Cross-Linked Injectable PEG Hydrogel with Robust Hemostatic and Antibacterial Properties
Gels · 20.06.2026 · 12 (6) · 556
DOI: 10.3390/gels12060556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 20.06.2026. Verfasst von Jun Zhai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shaoxing Science and Technology Bureau, Shengzhou Innovation Research Institute of Zhejiang Sci-Tech Universit, Shaoxing Industry-University-Research Collaborative Research and Development Project.
Abstract (Originalsprache)
The rapid hemostasis of deep and irregular wounds is of great clinical significance. In this study, an injectable hemostatic hydrogel based on bioorthogonal conjugation was developed. This gel uses thrombin (TMB) as the hemostatic active substance and 4ARM-PEG-N3 as the crosslinking agent, which undergo orthogonal conjugation via the classic azide–alkyne click reaction to form an injectable hydrogel (TMB-PEG). The resulting hydrogel exhibited a transparent, injectable gel state. TEM images revealed that the hydrogel comprised sheet-like structures and interwoven fibers with a diameter of approximately 100 nanometers. In a puncture bleeding wound model, hemostasis with the TMB-PEG hydrogel required only 25 s, with a blood loss of 1.9 ± 1.3 mg, both approximately one-sixth of that of the control group. Moreover, the hemostatic performance of the TMB-PEG hydrogel was far superior to that of three other commonly used hemostatic materials. Furthermore, cephalosporin antibiotics were conjugated to the hemostatic gel via orthogonal reactions, endowing it with significant broad-spectrum antibacterial activity, achieving over 99% antibacterial efficacy against both Gram-negative and Gram-positive bacteria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China.
- Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University, Shengzhou 312400, China.
- Department of Ultrasound in Medicine, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, N1 Shangcheng Avenue, Yiwu 322000,…
- Zhejiang Dongbang Pharmaceutical Co., Ltd., Linhai 317022, China.
ORCID-Profile: Yong-Miao Shen
Förderung
- Shaoxing Science and Technology Bureau
- Shengzhou Innovation Research Institute of Zhejiang Sci-Tech Universit
- Shaoxing Industry-University-Research Collaborative Research and Development Project
- Shengzhou Innovation Research Institute of Zhejiang Sci-Tech University
Zitieren
APA
Zhai, J., Huang, Q., Ni, L., Li, C., Hao, L., Chen, J., Chi, C., Li, R., Shen, Y. M., Lu, R., & Zhang, Z. (2026). Bioorthogonally Cross-Linked Injectable PEG Hydrogel with Robust Hemostatic and Antibacterial Properties. Gels, 12(6), 556. https://doi.org/10.3390/gels12060556
Vancouver
Zhai J, Huang Q, Ni L, Li C, Hao L, Chen J, et al. Bioorthogonally Cross-Linked Injectable PEG Hydrogel with Robust Hemostatic and Antibacterial Properties. Gels. 2026;12(6):556. doi:10.3390/gels12060556
BibTeX
@article{Zhai2026,
author = {Zhai, Jun and Huang, Qiwen and Ni, Lei and Li, Chenming and Hao, Li and Chen, Jian and Chi, Cheng and Li, Risheng and Shen, Yong-Miao and Lu, Ronggui and Zhang, Zhijun},
title = {Bioorthogonally Cross-Linked Injectable PEG Hydrogel with Robust Hemostatic and Antibacterial Properties},
journal = {Gels},
year = {2026},
volume = {12},
number = {6},
pages = {556},
doi = {10.3390/gels12060556}
}
EUVIMED